dehydroepiandrosterone sulfate has been researched along with Benign Hypothalamic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bode, HH; Boepple, PA; Crawford, JD; Crigler, JF; Crowley, WF; Mansfield, MJ; Rudlin, CR; Wierman, ME | 1 |
1 review(s) available for dehydroepiandrosterone sulfate and Benign Hypothalamic Neoplasms
| Article | Year |
|---|---|
Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
Topics: Adrenal Glands; Adrenal Hyperplasia, Congenital; Bone Development; Child; Child, Preschool; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Female; Gonadotropin-Releasing Hormone; Growth Hormone; Hamartoma; Humans; Hypothalamic Neoplasms; Insulin-Like Growth Factor I; Luteinizing Hormone; Male; Pituitary Hormone-Releasing Hormones; Puberty, Precocious; Testosterone; Triptorelin Pamoate | 1986 |